| 标题 |
Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:Cruellas M, Rodriguez-Hernandez A, Carità L, Seguí E, Cejuela M, Lema L, García-Torralba E, Roqué-Lloveras A, Fernández-Ortega A, Melé M, Tapia M, Servitja S, González-Santiago S, Blaya-Boluda N, Bellet M, Martínez-Sáez O, Pimentel I, García-Fructuoso I, Pascual T, Joval-Ramentol L, Viñas G, Rey Aceituno M, Casas A, Castillo E, Brasó-Maristany F, Vivancos A, Serra V, Villacampa G, Oliveira M, Prat A, Saura C, Adamo B, Balmaña J 出版日期:2026-07-22 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)